EICHORCondition: Platinum-resistant Ovarian Cancer · Sponsor: Genmab
The purpose of this Chinese extension study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo. This study is an extension study of the protocol GCT1184-02 (NCT06619236).
This description comes directly from the study's public registry record.
Genmab Trial Information · +4570202728 · clinicaltrials@genmab.com
Always discuss trial participation with your own doctor first.
| Beijing Cancer Hospital | Beijing, China | — |
| Peking Union Medical College Hospital | Beijing, China | — |
| Chongqing University Cancer Hospital - Chongqing Cancer Hospital | Chongqing, China | — |
| Fujian Provincial Cancer Hospital | Fujian, China | — |
| Sun Yat-Sen Memorial Hospital | Guangdong, China | — |
| Sun Yat-Sen University Cancer Center | Guangdong, China | — |
| Harbin Medical University Cancer Hospital | Heilongjiang, China | — |
| Henan Cancer Hospital | Henan, China | — |
| Hunan Cancer Hospital | Hunan, China | — |
| Nanjing Drum Tower Hospital (The Affiliated Hospital of Nanjing University Medical School) | Jiangsu, China | — |
| The First Hospital of Jilin University | Jilin City, China | — |
| Liaoning Cancer Hospital | Liaoning, China | — |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07604766